{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:23Z","timestamp":1787022863526,"version":"build-2736575974"},"reference-count":58,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.16-404","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T18:06:13Z","timestamp":1478196373000},"page":"672-675","source":"Crossref","is-referenced-by-count":38,"title":["Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure"],"prefix":"10.1536","volume":"57","author":[{"given":"Yasufumi","family":"Katanasaka","sequence":"first","affiliation":[{"name":"Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka"},{"name":"Division of Translational Research, Kyoto Medical Center, National Hospital Organization"},{"name":"Shizuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sunagawa","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka"},{"name":"Division of Translational Research, Kyoto Medical Center, National Hospital Organization"},{"name":"Shizuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Translational Research, Kyoto Medical Center, National Hospital Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka"},{"name":"Division of Translational Research, Kyoto Medical Center, National Hospital Organization"},{"name":"Shizuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358: 1370-80. (Review)","DOI":"10.1056\/NEJMra072139"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7: 589-600. (Review)","DOI":"10.1038\/nrm1983"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 2003; 92: 1079-88. (Review)","DOI":"10.1161\/01.RES.0000072977.86706.23"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Paradis P, MacLellan WR, Belaguli NS, Schwartz RJ, Schneider MD. Serum response factor mediates AP-1-dependent induction of the skeletal alpha-actin promoter in ventricular myocytes. J Biol Chem 1996; 271: 10827-33.","DOI":"10.1074\/jbc.271.18.10827"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Katanasaka Y, Sunagawa Y, Hasegawa K, Morimoto T. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes. Biol Pharm Bull 2013; 36: 13-7. (Review)","DOI":"10.1248\/bpb.b212022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Herzig TC, Jobe SM, Aoki H, <i>et al<\/i>. Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci U S A 1997; 94: 7543-8.","DOI":"10.1073\/pnas.94.14.7543"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakagawa Y, Kuwahara K, Harada M, <i>et al<\/i>. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J Mol Cell Cardiol 2006; 41: 1010-22.","DOI":"10.1016\/j.yjmcc.2006.08.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Molkentin JD. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 2004; 63: 467-75. (Review)","DOI":"10.1016\/j.cardiores.2004.01.021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Xing W, Zhang TC, Cao D, <i>et al<\/i>. Myocardin induces cardiomyocyte hypertrophy. Circ Res 2006; 98: 1089-97.","DOI":"10.1161\/01.RES.0000218781.23144.3e"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McCulley DJ, Black BL. Transcription factor pathways and congenital heart disease. Curr Top Dev Biol 2012; 100: 253-77. (Review)","DOI":"10.1016\/B978-0-12-387786-4.00008-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tong YF. Mutations of NKX2.5 and GATA4 genes in the development of congenital heart disease. Gene 2016; 588: 86-94.","DOI":"10.1016\/j.gene.2016.04.061"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kuo CT, Morrisey EE, Anandappa R, <i>et al<\/i>. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 1997; 11: 1048-60.","DOI":"10.1101\/gad.11.8.1048"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Crispino JD, Lodish MB, Thurberg BL, <i>et al<\/i>. Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 2001; 15: 839-44.","DOI":"10.1101\/gad.875201"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 2001; 276: 30245-53.","DOI":"10.1074\/jbc.M102174200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kakita T, Hasegawa K, Morimoto T, Kaburagi S, Wada H, Sasayama S. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. J Biol Chem 1999; 274: 34096-102.","DOI":"10.1074\/jbc.274.48.34096"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Morimoto T, Hasegawa K, Kaburagi S, <i>et al<\/i>. GATA-5 is involved in leukemia inhibitory factor-responsive transcription of the beta-myosin heavy chain gene in cardiac myocytes. J Biol Chem 1999; 274: 12811-8.","DOI":"10.1074\/jbc.274.18.12811"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shiojima I, Komuro I, Oka T, <i>et al<\/i>. Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx\/Nkx-2.5 and GATA-4. J Biol Chem 1999; 274: 8231-9.","DOI":"10.1074\/jbc.274.12.8231"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Belaguli NS, Sepulveda JL, Nigam V, Charron F, Nemer M, Schwartz RJ. Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol Cell Biol 2000; 20: 7550-8.","DOI":"10.1128\/MCB.20.20.7550-7558.2000"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kakita T, Hasegawa K, Iwai-Kanai E, <i>et al<\/i>. Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res 2001; 88: 1239-46.","DOI":"10.1161\/hh1201.091794"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Oka T, Maillet M, Watt AJ, <i>et al<\/i>. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 2006; 98: 837-45.","DOI":"10.1161\/01.RES.0000215985.18538.c4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kim Y, Ma AG, Kitta K, <i>et al<\/i>. Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 2003; 63: 368-77.","DOI":"10.1124\/mol.63.2.368"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kobayashi S, Lackey T, Huang Y, <i>et al<\/i>. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J 2006; 20: 800-2.","DOI":"10.1096\/fj.05-5426fje"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shan X, Xu X, Cao B, <i>et al<\/i>. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia\/reperfusion injury. Int J Cardiol 2009; 134: 384-92.","DOI":"10.1016\/j.ijcard.2008.03.043"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yanazume T, Hasegawa K, Morimoto T, <i>et al<\/i>. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003; 23: 3593-606.","DOI":"10.1128\/MCB.23.10.3593-3606.2003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Miyamoto S, Kawamura T, Morimoto T, <i>et al<\/i>. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 2006; 113: 679-90.","DOI":"10.1161\/CIRCULATIONAHA.105.585182"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Takaya T, Kawamura T, Morimoto T, <i>et al<\/i>. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J Biol Chem 2008; 283: 9828-35.","DOI":"10.1074\/jbc.M707391200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sunagawa Y, Morimoto T, Takaya T, <i>et al<\/i>. Cyclin-dependent kinase-9 is a component of the p300\/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes. J Biol Chem 2010; 285: 9556-68.","DOI":"10.1074\/jbc.M109.070458"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Trivedi CM, Zhu W, Wang Q, <i>et al<\/i>. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev Cell 2010; 19: 450-9.","DOI":"10.1016\/j.devcel.2010.08.012"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Morimoto T, Hasegawa K, Kaburagi S, <i>et al<\/i>. Phosphorylation of GATA-4 is involved in alpha 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes. J Biol Chem 2000; 275: 13721-6.","DOI":"10.1074\/jbc.275.18.13721"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kitta K, Cl\u00e9ment SA, Remeika J, Blumberg JB, Suzuki YJ. Endothelin-1 induces phosphorylation of GATA-4 transcription factor in the HL-1 atrial-muscle cell line. Biochem J 2001; 359: 375-80.","DOI":"10.1042\/bj3590375"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010; 90: 1507-46. (Review)","DOI":"10.1152\/physrev.00054.2009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 2001; 21: 7460-9.","DOI":"10.1128\/MCB.21.21.7460-7469.2001"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Liao P, Georgakopoulos D, Kovacs A, <i>et al<\/i>. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci U S A 2001; 98: 12283-8.","DOI":"10.1073\/pnas.211086598"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yanazume T, Hasegawa K, Wada H, <i>et al<\/i>. Rho\/ROCK pathway contributes to the activation of extracellular signal-regulated kinase\/GATA-4 during myocardial cell hypertrophy. J Biol Chem 2002; 277: 8618-25.","DOI":"10.1074\/jbc.M107924200"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nakajima K, Inagawa M, Uchida C, <i>et al<\/i>. Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway. Development 2011; 138: 1771-82.","DOI":"10.1242\/dev.059295"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yamak A, Latinkic BV, Dali R, Temsah R, Nemer M. Cyclin D2 is a GATA4 cofactor in cardiogenesis. Proc Natl Acad Sci U S A 2014; 111: 1415-20.","DOI":"10.1073\/pnas.1312993111"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Morisco C, Seta K, Hardt SE, Lee Y, Vatner SF, Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 2001; 276: 28586-97.","DOI":"10.1074\/jbc.M103166200"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kerkela R, Kockeritz L, Macaulay K, <i>et al<\/i>. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 2008; 118: 3609-18.","DOI":"10.1172\/JCI36245"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Tremblay JJ, Viger RS. Transcription factor GATA-4 is activated by phosphorylation of serine 261 via the cAMP\/protein kinase a signaling pathway in gonadal cells. J Biol Chem 2003; 278: 22128-35.","DOI":"10.1074\/jbc.M213149200"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Li T, Liu Z, Hu X, Ma K, Zhou C. Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4. Biochim Biophys Acta 2012; 1823: 582-92.","DOI":"10.1016\/j.bbamcr.2011.12.009"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Jun JH, Shim JK, Ryoo HM, Kwak YL. Erythropoietin-activated ERK\/MAP kinase enhances GATA-4 acetylation via phosphorylation of serine 261 of GATA-4. J Cell Physiol 2013; 228: 190-7.","DOI":"10.1002\/jcp.24121"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wang J, Paradis P, Aries A, <i>et al<\/i>. Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 2005; 25: 9829-44.","DOI":"10.1128\/MCB.25.22.9829-9844.2005"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. He A, Shen X, Ma Q, <i>et al<\/i>. PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev 2012; 26: 37-42.","DOI":"10.1101\/gad.173930.111"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Komatsu T, Mizusaki H, Mukai T, <i>et al<\/i>. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein\/steroidogenic factor 1 (Ad4BP\/SF-1) regulates synergistic transcription between Ad4BP\/SF-1 and Sox9. Mol Endocrinol 2004; 18: 2451-62.","DOI":"10.1210\/me.2004-0173"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Wang J, Feng XH, Schwartz RJ. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity. J Biol Chem 2004; 279: 49091-8.","DOI":"10.1074\/jbc.M407494200"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Wang J, Schwartz RJ. Sumoylation and regulation of cardiac gene expression. Circ Res 2010; 107: 19-29. (Review)","DOI":"10.1161\/CIRCRESAHA.110.220491"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Belaguli NS, Zhang M, Garcia AH, Berger DH. PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation. PLoS One 2012; 7: e35717.","DOI":"10.1371\/journal.pone.0035717"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Molkentin JD, Lu JR, Antos CL, <i>et al<\/i>. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-28.","DOI":"10.1016\/S0092-8674(00)81573-1"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Morimoto T, Hasegawa K, Wada H, <i>et al<\/i>. Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes. J Biol Chem 2001; 276: 34983-9.","DOI":"10.1074\/jbc.M005498200"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Pikkarainen S, Tokola H, Kerkela R, Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc Res 2004; 63: 196-207. (Review)","DOI":"10.1016\/j.cardiores.2004.03.025"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Hirai M, Ono K, Morimoto T, <i>et al<\/i>. FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes. J Biol Chem 2004; 279: 37640-50.","DOI":"10.1074\/jbc.M401737200"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Carrasco M, Delgado I, Soria B, Martin F, Rojas A. GATA4 and GATA6 control mouse pancreas organogenesis. J Clin Invest 2012; 122: 3504-15.","DOI":"10.1172\/JCI63240"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. van Berlo JH, Aronow BJ, Molkentin JD. Parsing the roles of the transcription factors GATA-4 and GATA-6 in the adult cardiac hypertrophic response. PLoS One 2013; 8: e84591.","DOI":"10.1371\/journal.pone.0084591"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Tevosian SG, Jim\u00e9nez E, Hatch HM, <i>et al<\/i>. Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors. Endocrinology 2015; 156: 2503-17.","DOI":"10.1210\/en.2014-1815"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Suzuki H, Katanasaka Y, Sunagawa Y, <i>et al<\/i>. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4. Biochim Biophys Acta 2016; 1862: 1544-57.","DOI":"10.1016\/j.bbadis.2016.05.006"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Morimoto T, Sunagawa Y, Kawamura T, <i>et al<\/i>. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008; 118: 868-78.","DOI":"10.1172\/JCI33160"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Morimoto T, Sunagawa Y, Fujita M, Hasegawa K. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ J 2010; 74: 1059-66.","DOI":"10.1253\/circj.CJ-09-1012"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Schiattarella GG, Hill JA. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation 2015; 131: 1435-47. (Review)","DOI":"10.1161\/CIRCULATIONAHA.115.013894"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/6\/57_16-404\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:45:42Z","timestamp":1498344342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/6\/57_16-404\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-404","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}